Clinical Trial

Hot Compress Application in Open Abdominal Surgery

Study acronym: HotCompress
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 6, 2025 (before its estimated February 15, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the effect of hot compress application to the intestines during abdominal surgery on postoperative nausea-vomiting and bowel function. Volunteers will be randomly assigned to the intervention and control groups. Initially, 30 patients will be included in each group, and the study will be completed based on the effect size determined by power analysis. Hypotheses: H0: Covering the intestines with saline heated at 36°C during surgery has no effect on postoperative nausea and vomiting. H1: Covering the intestines with saline heated at 36°C during surgery affects postoperative nausea and vomiting. H01: Covering the intestines with saline heated at 36°C during surgery has no effect on postoperative bowel function. H11: Covering the intestines with saline heated at 36°C during surgery affects postoperative bowel function. Inclusion Criteria: Undergoing abdominal surgery in the general surgery ward, Aged 18 years or older, Having a BMI between 18.50-24.99 kg/m², Able to communicate verbally, Willing to participate in the study, Conscious and oriented patients. Exclusion Criteria: History of previous gastrointestinal surgery, Postoperative complications, History of small bowel resection, ileostomy, or colostomy, History of emergency surgery, neoadjuvant therapy, appendectomy, or inflammatory bowel disease, Chronic opioid use, Chronic constipation (≤ 2 bowel movements per week), History of abdominal radiotherapy, Admission to the intensive care unit or postoperative bleeding. Application: Intervention Group: Routine preoperative procedures will be performed. During surgery, the intestines will be covered with sterile gauze soaked in saline heated at 36°C to prevent drying and reduce the risk of infection. Routine postoperative procedures will also be applied. Control Group: Routine preoperative, intraoperative, and postoperative procedures will be applied. During surgery, the intestines will be covered with sterile gauze soaked in unheated saline, following standard practice. Outcome Measures: Primary Outcome: Gastrointestinal function assessment index, including time to first flatulence, first defecation, first normal bowel sounds, and first consumption of liquid/semi-solid food. Secondary Outcome: Gastrointestinal symptoms such as nausea, abdominal bloating, pain, and vomiting.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-14; most recent amendment 2025-10-01.
Status change: Not Yet Recruiting → Recruiting 2025-10-01
Trial Details
NCT Number NCT06888154
Lead Sponsor TC Erciyes University
Collaborators: Kirsehir Ahi Evran Universitesi
Conditions Abdominal Surgery by Laparotomy
Enrollment 80 participants
Start Date 2025-05-15
Primary Completion 2026-02-15 (estimated)
Study Completion 2026-02-25 (estimated)
Updated on ClinicalTrials.gov 2025-10-06